| Tag | Content |
|---|
EnhancerAtlas ID | HS093-19931 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr20:61612400-61613020 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| REST | MA0138.2 | chr20:61612898-61612919 | GGCTCTGTCCGTGGTGCAGGG | - | 7.08 | | ZNF263 | MA0528.1 | chr20:61612710-61612731 | TCTCCCCTCCCCCCCTTCCCC | - | 6.77 | | ZNF263 | MA0528.1 | chr20:61612702-61612723 | CTCCCCCCTCTCCCCTCCCCC | - | 7.28 | | ZNF263 | MA0528.1 | chr20:61612711-61612732 | CTCCCCTCCCCCCCTTCCCCC | - | 7.53 | | ZNF263 | MA0528.1 | chr20:61612718-61612739 | CCCCCCCTTCCCCCCTCCCCC | - | 8.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_61729 | chr20:61582322-61623045 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH20I062980 | chr20 | 61611520 | 61612429 | | GH20I062981 | chr20 | 61612441 | 61612650 |
|
Enhancer Sequence | GGTGACAGGC ACGGAGCCGC TTGGCGGGAG GGGCTCAGGC AGCCTCCTGT CGGCTGAAAC 60
GCGCGGCCAC ACGAGAGCTC GGCTGCGTTC CGGGACTGGC GTAATTGGCA GGCTCCAGGC 120
AAGAGCGCTC ATGCTGACTG GCGCCTTTGC TGGGACTTGA AAGCAGGGGA GGGGATGTGC 180
CTGTCTCCTT GAGAGGAGAA CAAATGTTCC CTTTGAAGAA GTTTGCGATG AGCGGGGCCA 240
GTGTCAGAGG AGATGGCTTC TGGGGTGGCG GGCGGTGGCG GCAGGTGGCG CTGGCCCTGC 300
CCCTCCCCCC TCTCCCCTCC CCCCCTTCCC CCCTCCCCCC AGCAACCTCC GTGGGTCTCT 360
CCTTTGGGGC AGTCTCAGCT GGGTGGGCGC CGCTGCCACC CGCGTCCTCA AAGTCACTCT 420
TGCTGTTGTC CCTTCTGTGC ATCAGAGTGG GGCCGTGTGC GCCCTTCTGG GGTTCCTGCT 480
GGACTCCCCT CGGCCCCAGG CTCTGTCCGT GGTGCAGGGA GGTCCCGCCA TCCACCCAGG 540
CTCAGAAAAT AGCATGAATC AGCTCATGCA GTGGGGAAGT GGGACCCTGG GCTAGGGGAA 600
GCCAGGGGCA GTGTCCTCAG 620
|
